Wednesday, January 28, 2026 | 08:34 PM ISTहिंदी में पढें
Glenmark Pharmaceuticals Ltd
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31 2025.
05:23 PM, 19th Jan 2026
Glenmark Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31 2025.